Auxly Cannabis Group stock analysis
Auxly Cannabis Group (0UO5) Share Price & Analysis
0UO5 Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- CAD 366.49M
- Enterprise Value
- CAD 405.90M
- Total Cash (Recent Filing)
- CAD 38.95M
- Total Debt (Recent Filing)
- CAD 53.67M
- Price to Earnings (P/E)
- 11.0
- Beta
- 0.00
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- 0.08
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Above-market Revenue And EBITDA Growth
Strong year-over-year revenue growth paired with faster adjusted EBITDA growth indicates improving operating leverage rather than growth purchased solely through higher spending. If sustained, this combination can strengthen earnings power, support reinvestment, and help Auxly outgrow the Canadian cannabis market.
Durable Manufacturing And Procurement Gains
Management characterizes the operating improvements behind stable margins as permanent investments, supported by better yields, manufacturing processes, efficiency, and procurement. That suggests the benefits can remain embedded in the cost structure and support profitability beyond a single reporting period.
Brand And Product Leadership
Leading positions across major cannabis formats provide evidence of consumer traction and brand strength in a competitive regulated market. Strong sell-through can improve distribution relevance, support shelf access, and create a durable platform for launching additional products such as new cultivars.
Bears Say
Recent Margin Compression
The sharp reduction in gross margin shows that profitability remains exposed to cost or pricing pressure even after the turnaround. Sustained compression would reduce the cash available for capacity investment, weaken operating leverage, and make future earnings more sensitive to product mix and market pricing.
Vape Pricing And Input-cost Risk
Vapes are strategically important but have fewer barriers to entry, creating persistent pricing pressure in a competitive category. If distillate costs rise while prices remain compressed, the category could dilute overall margins and limit the profitability of Auxly’s product innovation and volume growth.
B2B Volume And Pricing Pressure
Lower B2B volumes and prices indicate that channel economics can offset internal productivity improvements. Continued weakness in this business could constrain revenue quality and gross-profit expansion, forcing Auxly to rely more heavily on branded consumer demand and execution in retail-facing formats.
Auxly Cannabis Group News
0UO5 FAQ
What is Auxly Cannabis Group’s market cap?
When is Auxly Cannabis Group’s upcoming earnings report date?
How were Auxly Cannabis Group’s earnings last quarter?
Is Auxly Cannabis Group overvalued?
Does Auxly Cannabis Group pay dividends?
What is Auxly Cannabis Group’s EPS estimate?
What happened to Auxly Cannabis Group’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Auxly Cannabis Group?
What is the TipRanks Smart Score and how is it calculated?
Auxly Cannabis Group Stock Smart Score
Company Description
Auxly Cannabis Group
Auxly Cannabis Group Inc. operates as a Canadian consumer packaged goods (CPG) firm focused on the cannabis market. Its primary activities include the development, manufacturing, and distribution of cannabis products, targeting both recreational and wellness consumers. The company offers a wide array of cannabis formats under its distinct brands—KOLAB PROJECT, Dosecann, BACK FORTY, and Foray—including vape cartridges, dried flower, concentrates, chocolates, soft chews, oil drops, capsules, topicals, and hard candy. Originally incorporated in 1987, the company was known as Cannabis Wheaton Income Corp. before officially changing its name to Auxly Cannabis Group Inc. in June 2018. It is headquartered in Toronto, Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hugo Alves
- Employees
- 446
- Website
- auxly.com
- Address
- 777 Richmond Street West, Toronto, ON, M6J 0C2, CA
Auxly Cannabis Group (0UO5) Earnings & Revenues
0UO5 Earnings Call
Earnings Call SentimentPositive
The call was strongly positive, supported by quarterly records in revenue, adjusted EBITDA and cash flow, stable 56% gross margins, strong cash conversion, brand and product leadership, planned capacity expansion and a favorable Canadian market outlook. The main challenges were lower B2B volumes and prices, structural margin pressure in vapes, potential future distillate cost increases, evolving international regulations and incomplete national excise-stamp harmonization. Highlights significantly outweighed the lowlights.
View all GB:0UO5 earnings summaries










